Condition
Osmotic Demyelination Syndrome
Total Trials
3
Recruiting
0
Active
1
Completed
0
Key Insights
Highlights
No notable highlights available yet
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 3 trials
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 0 completed with results
Key Signals
Data Visualizations
Phase Distribution
1Total
Not Applicable (1)
Trial Status
Active Not Recruiting1
Enrolling By Invitation1
Unknown1
Clinical Trials (3)
Showing 3 of 3 trials
NCT07576036Enrolling By Invitation
International Multi-center Retrospective Study of Patients With Serum Sodium ≤110 mmol/L to Determine the Relationship Between Osmotic Demyelination Syndrome (ODS) and Rapid Correction of Hyponatremia
NCT07430787Active Not Recruiting
Hyponatremia - Complications, Prognosis, Epidemiology in Finnish Tertiary Care
NCT04561531Not ApplicableUnknown
Efficacy and Safety of Bolus Comparing With Continuous Drip of 3% NaCl in Patients With Severe Symptomatic Hyponatremia.
Showing all 3 trials